| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |